{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:19Z","timestamp":1790677399256,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0163493","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T13:46:36Z","timestamp":1475761596000},"page":"e0163493","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Muscle MRI Findings in Childhood\/Adult Onset Pompe Disease Correlate with Muscle Function"],"prefix":"10.1371","volume":"11","author":[{"given":"Sebasti\u00e1n","family":"Figueroa-Bonaparte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Llauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaskun","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00edda","family":"Alejaldre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Mayos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Su\u00e1rez-Cuart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"D\u00edaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Spanish Pompe Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"issue":"9646","key":"ref1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"AT van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"BL Thurberg","year":"2006","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"issue":"Suppl 2","key":"ref3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"B Bembi","year":"2008","journal-title":"Neurology"},{"key":"ref4","article-title":"Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up","author":"D Gungor","year":"2015","journal-title":"Journal of inherited metabolic disease"},{"issue":"15","key":"ref5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"AT van der Ploeg","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"AT van der Ploeg","year":"2012","journal-title":"Molecular genetics and metabolism"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"A Toscano","year":"2013","journal-title":"Journal of neurology"},{"issue":"39","key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16390","article-title":"The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders","volume":"16","author":"K Wyatt","year":"2012","journal-title":"Health technology assessment"},{"issue":"8","key":"ref9","first-page":"497","article-title":"Clinical guidelines for late-onset Pompe disease","volume":"54","author":"MA Barba-Romero","year":"2012","journal-title":"Revista de neurologia"},{"issue":"7","key":"ref10","first-page":"321","article-title":"Guidelines for monitoring late-onset Pompe disease","volume":"60","author":"E Gutierrez-Rivas","year":"2015","journal-title":"Revista de neurologia"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"EJ Cupler","year":"2012","journal-title":"Muscle & nerve"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","article-title":"Muscle MRI in inherited neuromuscular disorders: past, present, and future","volume":"25","author":"E Mercuri","year":"2007","journal-title":"Journal of magnetic resonance imaging: JMRI"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0b013e3181ea1564","article-title":"Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies","volume":"75","author":"C Paradas","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0000000000000785","article-title":"Quantitative MRI in muscular dystrophy: An indispensable trial endpoint?","volume":"83","author":"KG Hollingsworth","year":"2014","journal-title":"Neurology"},{"issue":"Suppl 2","key":"ref15","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.nmd.2012.08.002","article-title":"TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25\u201326 February 2011, Rome, Italy","volume":"22","author":"V Straub","year":"2012","journal-title":"Neuromuscular disorders: NMD"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2011.10.003","article-title":"Distal myopathies\u2014new genetic entities expand diagnostic challenge","volume":"22","author":"B Udd","year":"2012","journal-title":"Neuromuscular disorders: NMD"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(15)00242-2","article-title":"MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study","volume":"15","author":"JM Morrow","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/nbm.3352","article-title":"Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy","volume":"28","author":"C Wary","year":"2015","journal-title":"NMR in biomedicine"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/01.wnl.0000324927.28817.9b","article-title":"Distinct muscle imaging patterns in myofibrillar myopathies","volume":"71","author":"D Fischer","year":"2008","journal-title":"Neurology"},{"key":"ref20","article-title":"Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes","author":"J Diaz-Manera","year":"2015","journal-title":"Neuromuscular disorders: NMD"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns","volume":"21","author":"RY Carlier","year":"2011","journal-title":"Neuromuscular disorders: NMD"},{"issue":"2\u20133","key":"ref22","first-page":"95","article-title":"Muscle MRI in muscular dystrophies","volume":"34","author":"J Diaz-Manera","year":"2015","journal-title":"Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology \/ edited by the Gaetano Conte Academy for the study of striated muscle diseases"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nmd.2015.05.006","article-title":"Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy","volume":"25","author":"U Bonati","year":"2015","journal-title":"Neuromuscular disorders: NMD"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mus.24437","article-title":"Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease","volume":"51","author":"JJ Horvath","year":"2015","journal-title":"Muscle & nerve"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jmri.21492","article-title":"Dixon techniques for water and fat imaging","volume":"28","author":"J Ma","year":"2008","journal-title":"Journal of magnetic resonance imaging: JMRI"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-010-9204-5","article-title":"Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response","volume":"33","author":"S Ravaglia","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1212\/WNL.0000000000000775","article-title":"Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS","volume":"83","author":"I Arpan","year":"2014","journal-title":"Neurology"},{"issue":"Suppl 2","key":"ref28","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.nmd.2012.05.011","article-title":"Trunk muscle involvement in late-onset Pompe disease: study of thirty patients","volume":"22","author":"A Alejaldre","year":"2012","journal-title":"Neuromuscular disorders: NMD"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jmri.23998","article-title":"Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients","volume":"38","author":"BH Wokke","year":"2013","journal-title":"Journal of magnetic resonance imaging: JMRI"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients","volume":"38","author":"PG Carlier","year":"2015","journal-title":"Journal of inherited metabolic disease"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mus.21304","article-title":"Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?","volume":"40","author":"A Pichiecchio","year":"2009","journal-title":"Muscle & nerve"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgmr.2015.03.010","article-title":"Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy","volume":"3","author":"KM Gruhn","year":"2015","journal-title":"Molecular genetics and metabolism reports"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0163493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:25:06Z","timestamp":1540225506000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0163493"}},"subtitle":[],"editor":[{"given":"Maurilio","family":"Sampaolesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0163493","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}